New Sealed in Box 100 OneTouch Ultra Blue Test Strips Expiration: 10/2023
On May 27th, 2022, Boson Rapid SARS-CoV-2 Antigen Test Card (Self-Testing) was authorized for marketing by Health Canada.Global Technology Foundation is a fully authorized independent distributor of Boson Biotechnology Co., Ltd. throughout North America. It has the ability to supply government and private buyers with a monthly supply of 30-40 million boxes. The quotation on this page is only for the USA .Sales, OTG supply, accept TT payment.The BOSONTM� Rapid SARS-CoV-2 Antigen Test Card (Home Test) has been sold to Europe, Southeast Asia, Australia, Canada and other countries, with excellent product quality and service. The test gained substantial popularity among users. The only supplier with the lowest price in North America for COVID-19 antigen test kits
The US Food and Drug Administration (FDA) granted Emergency Use Authorization for the BOSONTM Rapid SARS-CoV-2 Antigen Test Card (Home Test) on April 6, 2022. Global Technology Foundation is a fully authorized independent distributor of Boson Biotechnology Co., Ltd. throughout North America. It has the ability to supply government and private buyers with a monthly supply of 30-40 million boxes. The quotation on this page is only for the USA .Sales, DDP supply, accept TT payment.The BOSONTM� Rapid SARS-CoV-2 Antigen Test Card (Home Test) has been sold to Europe, Southeast Asia, Australia, Canada and other countries, with excellent product quality and service.  The test gained substantial popularity among users
SOP #1) ICPO, POF- Then fully financed, we move the product here and buyer must pay within 24hrs after it arrives CIF (Inspect and Pay) $7.89 - add comms CIF USA : Within 6 working days all packages will be arrived by air freight or #2) PAYMENT TERM PO , 50% after PO / 50% after BOL is provided. CIF USA : Within 6 working days all packages will be arrived by air freight $6.89 - add comms PO: Ruben L Hudson Advanced Healthcare Resources LLC c/o STM Bio - Goldmanifestor
Durex Condoms, 3 pack
Real Time Voice Analyzer Smartphone App Bulk Screening Tests for COVID, Flu, and other Respiratory Diseases on Smartphones using AI Technology Quantity Available: UNLIMITED Pricing: As low as $0.50 per test Product Website: RTVoiceTest.com Business Registration Website: RTNAccount.com The Real Time Voice Analyzer (RTVA) is an advanced AI screening app for Apple and Android smartphones that utilizes voice biomarkers and AI algorithms to detect airborne respiratory viruses, including COVID-19 and its variants and even some strains of influenza and the common cold. The RTVA app is Fast, Accurate, and Non-Invasive, and free to download. For more information and a Free Trial (no credit card needed), please visit: RTVoiceTest.com We offer bulk discounts on screening tests to large companies and organizations. With pricing as low as $0.50 per test, and UNLIMITED TESTING, the RTVA is ideal for large to very large groups. For more information, please contact:
First Aid Kits: Home FAK,Car FAK,Bike FAK,Office FAK,Pet FAK Different types of packaged kits, such as pouches, plastic case, metal case, etc. Different FAk with different components: Adhesive strips, cohesive bandage, gloves, gauze pad, cleaning wipes,scissors,tweezers,alcohol pads, survival rescue blanket ,adhesive tapes,triangular bandages. etc.
First Aid Kits: Home FAK,Car FAK,Bike FAK,Office FAK,Pet FAK Different types of packaged kits, such as pouches, plastic case, metal case, etc. Different FAk with different components: Adhesive strips, cohesive bandage, gloves, gauze pad, cleaning wipes,scissors,tweezers,alcohol pads, survival rescue blanket ,adhesive tapes,triangular bandages. etc.
BinaxNOW COVID-19 Antigen Self Test (2 tests for serial testing) A simple solution for COVID-19 infection detection, with rapid results. This test has received FDA Emergency Use Authorization for self-testing without the need to ship samples to a lab or for a prescription from your healthcare provider. This 15-minute test can be completed anytime, anywhere. Simply test yourself twice within 3 days, with at least 36 hours between tests. MOQ 50,000 Worldwide Shipping
Rapid Tests Kits OTG USA COVID-19 Rapid Urine Antibody Test (World's First and Only) COVID-19 IgG / IgM Rapid Antibody Detection Test COVID-19 Saliva Antigen Rapid POC Test COVID-19 Antigen Rapid POC Test (Nasal Swab Collection)
Covid-19 Rapid Test Kits Results in 15 Min - MOQ 100,000- $9.15 USD Each Test -FOB-Abbott Antigen BinaxNOW Covid-19 Self Test (Nasal) (No Blood-No Saliva)
Hotgen Covid 19 Rapid Test Kits-LOI for Pricing Outfront Marketing Medical LLC-MOQ 10K-Worldwide Shipping
Hello, I hope you are doing well. We have the following test kits. If you are interested please send an LOI: Outfront Marketing Medical LLC Doug@Outfrontmarketing.com Please include a location for delivery. We will then send you a formal Invoice and Instructions. These kits are selling fast. We have an allotment of 30M available 1/15/22. So place an order asap. MOQ 50K
DiaTrustâ?¢ COVID-19 Ag Rapid Test- 156 pallets available. 748,800 tests are readily available for pickup. Distrust covid-19-ag rapid antigen test 25ct box $9.35 ea test.
Certification - Health and safety evaluation report/Test report Daily manufacturer output - 500,000 Pcs Price - Quantity Derived
Due to contractual obligations to the federal government, Current suppliers have increased costs and limited production of all point of care tests without notice. We have great news! To shield our customers from excessive price increases as well as provide immediate availability, we have secured multiple FDA EUA rapid antigen test kit options. These tests have similar and/or better accuracy along with individual buffer bottles. We are currently able to provide three options: Clarity-Sienna, Indicaid and Celltrion DiaTrust kits. We work directly with the distributor and can supply by the pallet or case with pricing as low as $6.00 per kit.
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. - One tube reaction for identification and detection of 2019-nCoV - One-step Real-Time RT-PCR - Provide all reagents required for PCR - Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans" - nCoV primers/probes ORF1ab (RdRp) gene, E gene Provide Internal controls Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
